A Systematic Review of the Role of Penile Rehabilitation in Prostate Cancer Patients Receiving Radiotherapy and Androgen Deprivation Therapy

被引:5
作者
Doherty, Wesley [1 ]
Bridge, Pete [2 ]
机构
[1] Christie Hosp NHS Trust, Radiotherapy Dept, Manchester, Lancs, England
[2] Univ Liverpool, Directorate Radiotherapy, Liverpool, Merseyside, England
关键词
Prostate; radiotherapy; erectile dysfunction; penile rehabilitation; ERECTILE FUNCTION IIEF; QUALITY-OF-LIFE; SILDENAFIL CITRATE; RADIATION-THERAPY; DOUBLE-BLIND; PHOSPHODIESTERASE-5; INHIBITORS; RADICAL RADIOTHERAPY; INTERNATIONAL INDEX; OPEN-LABEL; DYSFUNCTION;
D O I
10.1016/j.jmir.2018.09.004
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Introduction/Background: Treatment-induced erectile dysfunction (ED) is a common side effect of radiotherapy and androgen deprivation therapy (ADT) that impacts on patient quality of life. Penile rehabilitation interventions including pharmacologic and physical therapies aim to reduce the impact of ED. Despite The National Institute for Health and Care Excellence guidelines recommending access to ED services, penile rehabilitation is not widely discussed or implemented. This systematic review aimed to appraise the evidence base for penile rehabilitation and identify evidence-based recommendations for practice. Methods: A systematic review of the evidence base was undertaken using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. The Scopus and Medline (EBSCO) databases were searched for articles relevant to penile rehabilitation interventions for prostate radiotherapy patients. Study quality was graded using the Oxford Levels of Evidence and the Scottish Intercollegiate Guidelines Network. Results: This study identified 19 articles on penile rehabilitation in prostate radiotherapy patients, consisting of eight randomized controlled trials, three systematic reviews, and eight case studies. Findings confirmed the value of early use of phosphodiesterase type 5 inhibitors. Discussion: Despite the range of available physical and pharmaceutical interventions, relevant research focussed solely on the use of phosphodiesterase type 5 inhibitors. Themes from the reviewed articles indicated that timing of intervention was important with early on-going dosage most useful. There was also an identified need for ongoing prophylactic use during ADT. Evidence, in general, was of low quality and based on quantitative data only. Conclusion: Additional research into the wider range of penile rehabilitation interventions is urgently required to ensure patients have access to those therapies that are most appropriate for them. A paradigm shift toward qualitative research in the field of penile rehabilitation for prostate cancer patients treated with radiotherapy and ADT may be of value in future studies.
引用
收藏
页码:171 / 178
页数:8
相关论文
共 50 条
  • [21] Effect of androgen deprivation therapy on cognitive functioning in men with prostate cancer: A systematic review
    Andela, Cornelie D.
    Matte, Rafil
    Jazet, Ingrid M.
    Zonneveld, Willemijn C. G.
    Schoones, Jan W.
    Meinders, A. Edo
    INTERNATIONAL JOURNAL OF UROLOGY, 2021, 28 (08) : 786 - 798
  • [22] Incidence of the adverse effects of androgen deprivation therapy for prostate cancer: a systematic literature review
    Edmunds, Kim
    Tuffaha, Haitham
    Galvao, Daniel A.
    Scuffham, Paul
    Newton, Robert U.
    SUPPORTIVE CARE IN CANCER, 2020, 28 (05) : 2079 - 2093
  • [23] Prostate cancer survivorship: a review of erectile dysfunction and penile rehabilitation after prostate cancer therapy
    Chung, Eric
    Gillman, Michael
    MEDICAL JOURNAL OF AUSTRALIA, 2014, 200 (10) : 582 - 585
  • [24] Feasibility and Safety of Physical Exercise to Preserve Bone Health in Men With Prostate Cancer Receiving Androgen Deprivation Therapy: A Systematic Review
    Cagliari, Maribel
    Bressi, Barbara
    Bassi, Maria Chiara
    Fugazzaro, Stefania
    Prati, Giuseppe
    Iotti, Cinzia
    Costi, Stefania
    PHYSICAL THERAPY, 2022, 102 (03):
  • [25] Psychological impact of prostate cancer on patients receiving a 6-month androgen deprivation therapy
    de la Taille, A.
    Mardoyan, S.
    Lafaye, A.
    PROGRES EN UROLOGIE, 2018, 28 (01): : 32 - 38
  • [26] Improving the management of patients with prostate cancer receiving long-term androgen deprivation therapy
    Schulman, C.
    Irani, J.
    Aapro, M.
    BJU INTERNATIONAL, 2012, 109 : 13 - 21
  • [27] Predictors of depression, anxiety and quality of life in patients with prostate cancer receiving androgen deprivation therapy
    Chipperfield, Kelly
    Fletcher, Jane
    Millar, Jeremy
    Brooker, Joanne
    Smith, Robin
    Frydenberg, Mark
    Burney, Sue
    PSYCHO-ONCOLOGY, 2013, 22 (10) : 2169 - 2176
  • [28] Association of androgen deprivation therapy with thromboembolic events in patients with prostate cancer: a systematic review and meta-analysis
    Guo, Zhenlang
    Huang, Yiyu
    Gong, Leiliang
    Gan, Shu
    Chan, Franky Leung
    Gu, Chiming
    Xiang, Songtao
    Wang, Shusheng
    PROSTATE CANCER AND PROSTATIC DISEASES, 2018, 21 (04) : 451 - 460
  • [29] Feasibility and safety of physical exercise in men with prostate cancer receiving androgen deprivation therapy and radiotherapy: a study protocol
    Bressi, Barbara
    Iotti, Cinzia
    Cagliari, Maribel
    Cavuto, Silvio
    Fugazzaro, Stefania
    Costi, Stefania
    BMJ OPEN, 2022, 12 (03):
  • [30] Radiotherapy and Androgen Deprivation for Prostate Cancer REPLY
    Jones, Christopher U.
    Hunt, Daniel
    Shipley, William U.
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (14) : 1354 - 1355